Application
SPTLC2 Antibody (Center) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the SPTLC2 antibody detected the SPTLC2 protein (arrow).| Product Name | SPTLC2 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SPTLC2; KIAA0526; LCB2; Serine palmitoyltransferase 2; Long chain base biosynthesis protein 2; Long chain base biosynthesis protein 2a; Serine-palmitoyl-CoA transferase 2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | KIAA0526 LCB2 |
|---|---|
| Alternative Names | SPTLC2 KIAA0526 LCB2 Serine palmitoyltransferase 2 Long chain base biosynthesis protein 2 Long chain base biosynthesis protein 2a Serine-palmitoyl-CoA transferase 2 |
| Molecular Weight(MW) | 62924 Da |
| Function | Serine palmitoyltransferase (SPT). The heterodimer formed with LCB1/SPTLC1 constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2-SPTSSA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC2-SPTSSB complex displays a preference for C18-CoA substrate |
| Tissue Specificity | Widely expressed. |
| Cellular Localization | Endoplasmic reticulum membrane; Single-pass membrane protein (By similarity) |
| Entrez Gene | 9517 |
|---|---|
| Nucleotide Accession | NP_004854.1 |
Application
SPTLC2 Antibody (Center) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the SPTLC2 antibody detected the SPTLC2 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
